About the Company
Cardiovascular Systems, Inc., based in St. Paul, Minn., is a medical device company focused on developing and commercializing innovative solutions for treating vascular and coronary disease. The company's orbital atherectomy system treats calcified and fibrotic plaque in arterial vessels throughout the leg and heart and addresses many of the limitations associated with existing surgical, catheter and pharmacological treatment alternatives.
Fundamental Data and Insider Transactions (Quarterly data) Full Screen
Loading the fundamentals chart...
Latest $CSII News
Revascularization enhances quality of life for patients with chronic limb threatening ischemia
Cardiovascular Systems Inc. As of September 1, 2022, ongoing BEST-CLI research is funded primarily by the Novo Nordisk Foundation. Paper cited: Menard, M. et al. “Quality of Life in Patients ...
Elective PCI Case: Prior CTA With High Calcium Score and MVD
Cardiovascular Systems, Inc.; Cordis Corporation, a Johnson & Johnson company; Penumbra; Philips; Shockwave Medical Receive the the latest news, research, and presentations from major meetings right ...
Abbott Reports First-Quarter 2024 Results and Raises Midpoint of Full-Year Guidance Ranges
The table above provides additional details regarding the specified items described on tables titled "Non-GAAP Reconciliation of Financial Information." Restructuring and cost reduction initiative ...
Merit Medical (MMSI) Q1 Earnings Top Estimates, Margins Up
Merit Medical Systems, Inc. MMSI delivered adjusted earnings per share (EPS) of 77 cents in the first quarter of 2024 compared with 64 cents in the year-ago period. The figure surpassed the Zacks ...
Cardiovascular Disease
While the term technically refers to any disease that affects the cardiovascular system (as used in MeSH C14), it is usually used to refer to those related to atherosclerosis (arterial disease).
Global Robotic Catheterization Systems Market Expected to Reach US$ 112.5 Million by 2029
The global market for robotic catheterization systems is projected to soar to US$ 112.5 million by the end of 2029, driven by ...
Titan Medical gives progress report about Conavi merger
Titan Medical and Conavi aim to commercialize Conavi’s Novasight Hybrid system for guiding common minimally invasive coronary ...
Your Guide to Improving Your Heart Health
That’s something your cardiovascular system will appreciate. There are many changes you can make to help keep your heart healthy and strong. Improving your diet, engaging in physical activity ...
Merit Medical Systems, Inc. (NASDAQ:MMSI) Q1 2024 Earnings Call Transcript
Q1 2024 Earnings Call Transcript April 30, 2024 Merit Medical Systems, Inc. isn’t one of the 30 most popular stocks among ...
Bank of America Securities Keeps Their Hold Rating on Merit Medical Systems (MMSI)
Merit Medical Systems, Inc. engages in the manufacture and market of proprietary disposable medical devices. It operates through Cardiovascular and Endoscopy segments. The Cardiovascular segment ...
Cardiopulmonary Stress Testing Systems Market Charting the Course Navigating Success through Future Market Sizing
Cardiopulmonary Stress Testing Systems Market is valued approximately USD 477 billion in 2019 and is anticipated to grow with a healthy growth rate of more than 5.90 % over the forecast period ...
Q1 2024 Merit Medical Systems Inc Earnings Call
Ladies and gentlemen, thank you for standing by. Welcome to MMSI first-quarter 2024 earnings call. (Operator Instructions) Please be advised that today's conference is being recorded. I would like now ...
Loading the latest forecasts...